오하이오의 혈액암 임상 시험
혈액암 관련 연구 22개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.
오하이오의 도시
공식 연구 텍스트(영어)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton
- 외 44개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중관찰 연구
0세 ~ 38세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06131801Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 8, Columbus
피험자 모집 중3상
18세 ~ 71세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- University of Cincinnati Medical Center, Cincinnati
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07648264Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Strecker Cancer Center-Belpre, Belpre
- Miami Valley Hospital South, Centerville
- Adena Regional Medical Center, Chillicothe
- 외 27개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT04242095A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- University of Cincinnati, Cincinnati
- OhioHealth Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
피험자 모집 중관찰 연구
0세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07154823Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Ohio State University, Columbus
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- UH Seidman Cancer Center, Cleveland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Gabrail Cancer Center, Canton
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06823167Weighted Blanket Use to Reduce Anxiety in Oncology Patients
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06089408A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Case Medical Center, Cleveland
- 외 3개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
피험자 모집 중1상
13세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT04771572CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Cleveland Clinic, Cleveland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT05178472A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Institute, Cleveland
- The James Cancer Hospital and Solove Research Institute, Columbus
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT05735184Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
- Gabrail Cancer Center, Canton
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 11. 업데이트됨 · NCT07036133A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- University of Cincinnati Medical Center, Cincinnati
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 6. 25. 업데이트됨 · NCT05768269IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- University Hospitals Cleveland, Cleveland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 6. 3. 업데이트됨 · NCT06119685αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
- Nationwide Children's Hospital, Columbus
피험자 모집 중
30세 이하 · 모든 성별 · 2025. 4. 2. 업데이트됨 · NCT06082947Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies, Cleveland
- Nationwide Children's Hospital, Columbus
피험자 모집 중1상
1세 ~ 21세 · 모든 성별 · 2024. 12. 6. 업데이트됨 · NCT05476770Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- University of Cincinnati, Cincinnati
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 11. 15. 업데이트됨 · NCT06034275ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.